<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hou Y</submitter><funding>the National Key R&amp;D Program</funding><funding>2022 Science and Technology Research Project of Jiangxi Education Department</funding><funding>the National Natural Science Foundation of China</funding><pagination>781</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11487458</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(8)</volume><pubmed_abstract>Cerebral ischemia-reperfusion injury (IRI), occurring after blood supply restoration, contributes significantly to stroke-related deaths. This study explored the combined impact and mechanisms of astragaloside IV (AS-IV), hydroxysafflor yellow A (HSYA), and their combination in mitigating IRI. Male Sprague-Dawley (SD) rats were randomized to the Sham, MCAO, MCAO+AS-IV, MCAO+HSYA, and MCAO+AS-IV+HSYA groups. Neurological deficits and cerebral infarction were examined after restoring the blood supply to the brain. Pathomorphological changes in the cerebral cortex were observed via HE staining. IL-1β and IL-18 were quantified using ELISA. The expression of NF-κB and GSDMD in the ischemic cerebrum was analyzed using immunohistochemistry. The expression levels of NLRP3, ASC, IL-1β, Caspase-1, a</pubmed_abstract><journal>Brain sciences</journal><pubmed_title>A Combination of Astragaloside IV and Hydroxysafflor Yellow A Attenuates Cerebral Ischemia-Reperfusion Injury via NF-κB/NLRP3/Caspase-1/GSDMD Pathway.</pubmed_title><pmcid>PMC11487458</pmcid><funding_grant_id>GJJ2200932</funding_grant_id><funding_grant_id>81973560</funding_grant_id><funding_grant_id>2019YFC1708604</funding_grant_id><funding_grant_id>2019YFC1708600</funding_grant_id><pubmed_authors>Yang J</pubmed_authors><pubmed_authors>Yan Z</pubmed_authors><pubmed_authors>He Y</pubmed_authors><pubmed_authors>Wan H</pubmed_authors><pubmed_authors>Ding Z</pubmed_authors><pubmed_authors>Hou Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Combination of Astragaloside IV and Hydroxysafflor Yellow A Attenuates Cerebral Ischemia-Reperfusion Injury via NF-κB/NLRP3/Caspase-1/GSDMD Pathway.</name><description>Cerebral ischemia-reperfusion injury (IRI), occurring after blood supply restoration, contributes significantly to stroke-related deaths. This study explored the combined impact and mechanisms of astragaloside IV (AS-IV), hydroxysafflor yellow A (HSYA), and their combination in mitigating IRI. Male Sprague-Dawley (SD) rats were randomized to the Sham, MCAO, MCAO+AS-IV, MCAO+HSYA, and MCAO+AS-IV+HSYA groups. Neurological deficits and cerebral infarction were examined after restoring the blood supply to the brain. Pathomorphological changes in the cerebral cortex were observed via HE staining. IL-1β and IL-18 were quantified using ELISA. The expression of NF-κB and GSDMD in the ischemic cerebrum was analyzed using immunohistochemistry. The expression levels of NLRP3, ASC, IL-1β, Caspase-1, a</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jul</publication><modification>2025-04-04T02:54:33.371Z</modification><creation>2025-04-04T02:54:33.371Z</creation></dates><accession>S-EPMC11487458</accession><cross_references><pubmed>39199474</pubmed><doi>10.3390/brainsci14080781</doi></cross_references></HashMap>